Hirano K, Ito M, Hartshorne DJ(1995).“Interaction of the ribosomal protein, L5, with protein phosphatase type 1.”.J. Biol. Chem.270(34): 19786–90.doi:10.1074/jbc.270.34.19786.PMID7649987.
Li J, Yang Y, Peng Y, et al.(2002).“Oncogenic properties of PPM1D located within a breast cancer amplification epicenter at 17q23.”.Nat. Genet.31(2): 133–4.doi:10.1038/ng888.PMID12021784.
Bulavin DV, Demidov ON, Saito S, et al.(2002).“Amplification of PPM1D in human tumors abrogates p53 tumor-suppressor activity.”.Nat. Genet.31(2): 210–5.doi:10.1038/ng894.PMID12021785.
Morimoto H, Okamura H, Haneji T(2002).“Interaction of protein phosphatase 1 delta with nucleolin in human osteoblastic cells.”.J. Histochem. Cytochem.50(9): 1187–93.doi:10.1177/002215540205000905.PMID12185196.
Imabayashi H, Mori T, Gojo S, et al.(2003).“Redifferentiation of dedifferentiated chondrocytes and chondrogenesis of human bone marrow stromal cells via chondrosphere formation with expression profiling by large-scale cDNA analysis.”.Exp. Cell Res.288(1): 35–50.doi:10.1016/S0014-4827(03)00130-7.PMID12878157.
Lu X, Bocangel D, Nannenga B, et al.(2004).“The p53-induced oncogenic phosphatase PPM1D interacts with uracil DNA glycosylase and suppresses base excision repair.”.Mol. Cell15(4): 621–34.doi:10.1016/j.molcel.2004.08.007.PMID15327777.
Yamaguchi H, Minopoli G, Demidov ON, et al.(2005).“Substrate specificity of the human protein phosphatase 2Cdelta, Wip1.”.Biochemistry44(14): 5285–94.doi:10.1021/bi0476634.PMID15807522.
Rual JF, Venkatesan K, Hao T, et al.(2005).“Towards a proteome-scale map of the human protein-protein interaction network.”.Nature437(7062): 1173–8.doi:10.1038/nature04209.PMID16189514.
Rauta J, Alarmo EL, Kauraniemi P, et al.(2006).“The serine-threonine protein phosphatase PPM1D is frequently activated through amplification in aggressive primary breast tumours.”.Breast Cancer Res. Treat.95(3): 257–63.doi:10.1007/s10549-005-9017-7.PMID16254685.
Fujimoto H, Onishi N, Kato N, et al.(2006).“Regulation of the antioncogenic Chk2 kinase by the oncogenic Wip1 phosphatase.”.Cell Death Differ.13(7): 1170–80.doi:10.1038/sj.cdd.4401801.PMID16311512.
Mendrzyk F, Radlwimmer B, Joos S, et al.(2006).“Genomic and protein expression profiling identifies CDK6 as novel independent prognostic marker in medulloblastoma.”.J. Clin. Oncol.23(34): 8853–62.doi:10.1200/JCO.2005.02.8589.PMID16314645.